P13726 (TF_HUMAN) Homo sapiens (Human)
Tissue factor UniProtKBInterProSTRINGInteractive Modelling
295 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
50 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor |
Heteromer P08709; | 2×CA; 1×MG; 1×PY3; | ||||
| Assess | ||||||
| Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor |
Heteromer P08709; | 1×BGC; 9×CA; 1×FUC; 10×TMA; 1×0Z7; | ||||
| Assess | ||||||
| Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor |
Heteromer P08709; | 1×BGC; 9×CA; 1×FUC; 22×TMA; 1×0Z7; 1×POL; | ||||
| Assess | ||||||
| Crystal Structure of tissue factor-factor VIIa complex |
Heteromer P08709; | 1×GLC; 1×FUL; 1×0Z6; 1×NAG; 1×CA; | ||||
| Assess | ||||||
| HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587 |
Heteromer | 1×GOL; | ||||
| Assess | ||||||
| A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9) |
Heteromer P01837; X5J519; | |||||
| Assess | ||||||
| Crystal structure of tissue factor in complex with humanized Fab D3h44 |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor |
Heteromer P08709; | 1×BGC; 1×FUC; 1×0Z6; 1×CA; 1×CIT; | ||||
| Assess | ||||||
| Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor |
Heteromer P08709; | 8×CA; 1×BGC; 1×FUC; 1×0Z6; 2×CAC; | ||||
| Assess | ||||||
| Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)… |
Heteromer P08709; | 8×CA; 1×CAC; 1×03R; | ||||
| Assess | ||||||
| Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII |
Heteromer P08709; | 2×CA; 1×BGC; | ||||
| Assess | ||||||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P08709; | 1×BGC; 1×FUC; 3×MG; 6×CA; 1×BEN; 1×NA; 2×CL; | ||||
| Assess | ||||||
| crystal structure of factor VII.stf complexed with pd0297121 |
Heteromer P08709; | 5×CA; 1×GIL; 1×GLC; 1×FUC; 1×NAG; | ||||
| Assess | ||||||
| Rubidium Sites in Blood Coagulation Factor VIIa |
Heteromer P08709; | 1×BGC; 1×FUC; 3×MG; 4×CA; 6×RB; 1×BEN; 4×CL; | ||||
| Assess | ||||||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P08709; | 1×BGC; 1×FUC; 2×MG; 7×CA; 1×0GE; 3×CL; 1×NA; | ||||
| Assess | ||||||
| Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in … |
Heteromer P08709; | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×NA; 2×ZN; 3×CL; 1×PBZ; | ||||
| Assess | ||||||
| Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. |
Heteromer P08709; | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×NA; 2×ZN; 3×CL; 1×BEN; | ||||
| Assess | ||||||
| Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 |
Heteromer P08709; | 1×ASO; 1×FUC; 9×CA; 1×24X; | ||||
| Assess | ||||||
| Crystal structure of DFPR-VIIa/sTF |
Heteromer P08709; | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×0G7; 1×NA; 2×ZN; 3×CL; | ||||
| Assess | ||||||
| Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble… |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×0Z6; 1×CAC; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue… |
Heteromer | |||||
| Assess | ||||||
| HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT |
Heteromer P00974; P08709; | 1×GLC; 1×FUC; 2×CA; | ||||
| Assess | ||||||
| Human factor viia-tissue factor complexed with highly selective peptide inhibitor |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×567; | ||||
| Assess | ||||||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzam… |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×3BP; | ||||
| Assess | ||||||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×P5B; | ||||
| Assess | ||||||
| Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×PSM; | ||||
| Assess | ||||||
| tf7a_3771 complex |
Heteromer P08709; | 1×771; 9×CA; 1×CAC; 1×FUC; 1×BGC; | ||||
| Assess | ||||||
| Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-… |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×359; | ||||
| Assess | ||||||
| Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged grou… |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×3CB; | ||||
| Assess | ||||||
| Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×PI0; | ||||
| Assess | ||||||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamid… |
Heteromer P08709; | 1×BGC; 1×FUC; 9×CA; 1×5PI; | ||||
| Assess | ||||||
| Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex |
Heteromer P08709; | 1×GLC; 1×FUC; 6×CA; 2×MG; 1×0GJ; 1×NA; 2×ZN; 3×CL; | ||||
| Assess | ||||||
| tf7a_4380 complex |
Heteromer P08709; | 1×380; 9×CA; 1×CAC; 1×FUC; 1×BGC; | ||||
| Assess | ||||||
| Crystal structure of the complex between human tissue factor extracellular domain and antibody 10H1… |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue f… |
Heteromer P08709; | 1×BGC; 1×FUC; 1×CA; | ||||
| Assess | ||||||
| Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble t… |
Heteromer P08709; | 1×GLC; 1×FUC; 1×CA; 1×0Z6; | ||||
| Assess | ||||||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P08709; | 1×FUC; 2×CA; 1×BGC; 1×0GE; 1×CL; | ||||
| Assess | ||||||
| Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor |
Heteromer P08709; | 1×6NH; | ||||
| Assess | ||||||
| Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala1… |
Heteromer P08709; | 1×CR9; | ||||
| Assess | ||||||
| Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and … |
Heteromer P08709; | 1×C1B; | ||||
| Assess | ||||||
| Novel 5-Azaindole Factor VIIa Inhibitors |
Heteromer P08709; | 1×7NH; | ||||
| Assess | ||||||
| Discovery of Novel Heterocyclic Factor VIIa Inhibitors |
Heteromer P08709; | 1×N1H; | ||||
| Assess | ||||||
| Human Class I Major Histocompatibility Complex, A02 allele, presenting LLGWVFAQV |
Heteromer A0A140T913; P61769; | |||||
| Assess | ||||||
| THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION | homo-2-mer | 2×SO4; | ||||
| Assess | ||||||
| EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR | homo-2-mer | |||||
| Assess | ||||||
| EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR | monomer | |||||
| Assess | ||||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | |||||
| Assess | ||||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | |||||
| Assess | ||||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | |||||
| Assess | ||||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1boy.1.A | monomer | 0.83 | 100.00 | |||
| Assess | ||||||
| 7wmv.1.B | monomer | 0.61 | 13.64 | |||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 1boy.1.A | monomer | 0.76 | 98.80 | ||
| Assess | ||||||